1. Home
  2. ABEO vs RLTY Comparison

ABEO vs RLTY Comparison

Compare ABEO & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.52

Market Cap

281.0M

Sector

Health Care

ML Signal

HOLD

Logo Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest

RLTY

Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest

HOLD

Current Price

$14.40

Market Cap

247.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABEO
RLTY
Founded
1974
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
281.0M
247.3M
IPO Year
1980
N/A

Fundamental Metrics

Financial Performance
Metric
ABEO
RLTY
Price
$5.52
$14.40
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$18.20
N/A
AVG Volume (30 Days)
1.4M
86.7K
Earning Date
11-12-2025
01-01-0001
Dividend Yield
N/A
9.35%
EPS Growth
N/A
N/A
EPS
1.29
N/A
Revenue
$400,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,590.36
N/A
P/E Ratio
$3.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.93
$11.38
52 Week High
$7.54
$14.60

Technical Indicators

Market Signals
Indicator
ABEO
RLTY
Relative Strength Index (RSI) 61.06 30.76
Support Level $4.80 $14.52
Resistance Level $5.61 $14.69
Average True Range (ATR) 0.27 0.17
MACD 0.03 -0.04
Stochastic Oscillator 91.63 14.46

Price Performance

Historical Comparison
ABEO
RLTY

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest

Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.

Share on Social Networks: